1-Deoxy-1-[6-[((3-Iodophenyl)methyl)amino]-9H-purin-9-yl]-N-methyl-β-D-ribofuranuronamide合成路线 （共 7 条）
反应条件
hydrogenchloride T=60°C; 4 h; Yield given;
参考文献
Journal of Medicinal Chemistry, , vol. 37, # 5 p. 636 - 646
反应条件
1: Et3N / ethanol / 16 h / 75 °C 2: 1N HCl / 4 h / 60 °C View Scheme
参考文献
Journal of Medicinal Chemistry, , vol. 37, # 5 p. 636 - 646
反应条件
1: CHCl3 / 0.25 h / 10 °C 2: Et3N / ethanol / 16 h / 75 °C 3: 1N HCl / 4 h / 60 °C View Scheme
参考文献
Journal of Medicinal Chemistry, , vol. 37, # 5 p. 636 - 646
反应条件
1: Et3N / ethanol / 16 h / 75 °C 2: 1N HCl / 4 h / 60 °C View Scheme
参考文献
Journal of Medicinal Chemistry, , vol. 37, # 5 p. 636 - 646
反应条件
1: 77 percent / ethanol / 6 h / Heating 2: 72 percent / NaBH4 / tetrahydrofuran / 8 h / Heating View Scheme
参考文献
Journal of Heterocyclic Chemistry, , vol. 37, # 2 p. 339 - 341
反应条件
1: 77 percent / ethanol / 6 h / Heating 2: 72 percent / NaBH4 / tetrahydrofuran / 8 h / Heating View Scheme
参考文献
Journal of Heterocyclic Chemistry, , vol. 37, # 2 p. 339 - 341
参考文献
Government of the United States of America, repres ented by The Secretary, Department of Health and; Ewha Womans University
Patent: US2005/256143 A1, 2005 ;
Location in patent: Page/Page column Sheet 1 of 3 ;
